Cargando…

Circulating Sclerostin Levels Are Positively Related to Coronary Artery Disease Severity and Related Risk Factors

Romosozumab is a newly available treatment for osteoporosis acting by sclerostin inhibition. Its cardiovascular safety has been questioned after finding excess cardiovascular disease (CVD)‐related events in a pivotal phase 3 trial. Previous studies of relationships between circulating sclerostin lev...

Descripción completa

Detalles Bibliográficos
Autores principales:	Frysz, Monika, Gergei, Ingrid, Scharnagl, Hubert, Smith, George Davey, Zheng, Jie, Lawlor, Deborah A, Herrmann, Markus, Maerz, Winfried, Tobias, Jon H
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley & Sons, Inc. 2021
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9377011/ https://www.ncbi.nlm.nih.gov/pubmed/34738659 http://dx.doi.org/10.1002/jbmr.4467

Ejemplares similares

Mendelian Randomization Analysis Reveals a Causal Influence of Circulating Sclerostin Levels on Bone Mineral Density and Fractures
por: Zheng, Jie, et al.
Publicado: (2019)

Bone Mineral Density Is Positively Related to Carotid Intima‐Media Thickness: Findings From a Population‐Based Study in Adolescents and Premenopausal Women
por: Frysz, Monika, et al.
Publicado: (2016)

Telomere length, vitamin B12 and mortality in persons undergoing coronary angiography: the Ludwigshafen risk and cardiovascular health study
por: Pusceddu, Irene, et al.
Publicado: (2019)

Association Between Age at Puberty and Bone Accrual From 10 to 25 Years of Age
por: Elhakeem, Ahmed, et al.
Publicado: (2019)

Relation of Age, Gender, and Bone Mass to Circulating Sclerostin Levels in Women and Men
por: Mödder, Ulrike I, et al.
Publicado: (2011)

Circulating Sclerostin and Irisin Are Related and Interact with Gender to Influence Adiposity in Adults with Prediabetes
por: Klangjareonchai, Theerawut, et al.
Publicado: (2014)

Associations between prenatal indicators of mechanical loading and proximal femur shape: findings from a population-based study in ALSPAC offspring
por: Frysz, Monika, et al.
Publicado: (2020)

Circulating levels of sclerostin are associated with cardiovascular mortality
por: Novo-Rodríguez, Cristina, et al.
Publicado: (2018)

Elevated Circulating Sclerostin Concentrations in Individuals With High Bone Mass, With and Without LRP5 Mutations
por: Gregson, Celia L., et al.
Publicado: (2014)

Sclerostin and Cardiovascular Disease
por: Tobias, Jonathan H.
Publicado: (2023)

Positive and Negative Regulators of Sclerostin Expression
por: Iwamoto, Rina, et al.
Publicado: (2022)

Effect of adrenocorticotropic hormone infusion on circulating sclerostin levels
por: Zaheer, Sarah, et al.
Publicado: (2021)

Cardiovascular risk algorithms in primary care: Results from the DETECT study
por: Grammer, Tanja B., et al.
Publicado: (2019)

Author Correction: Cardiovascular risk algorithms in primary care: Results from the DETECT study
por: Grammer, Tanja B., et al.
Publicado: (2020)

Sclerostin
por: Silverman, Stuart L.
Publicado: (2010)

Regulation of Circulating Sclerostin Levels by Sex Steroids in Women and in Men
por: Mödder, Ulrike IL, et al.
Publicado: (2011)

Circulating bioactive sclerostin levels in an Austrian population-based cohort
por: Kerschan-Schindl, Katharina, et al.
Publicado: (2021)

Anti-Sclerostin Antibody Inhibits Internalization of Sclerostin and Sclerostin-Mediated Antagonism of Wnt/LRP6 Signaling
por: van Dinther, Maarten, et al.
Publicado: (2013)

Circulating sclerostin is associated with bone mineral density independent of HIV-serostatus
por: Ross, Ryan D., et al.
Publicado: (2020)

Circulating Levels of Sclerostin Predict Glycemic Improvement after Sleeve Gastrectomy
por: Carbone, Federico, et al.
Publicado: (2021)

GWAS meta-analysis followed by Mendelian randomization revealed potential control mechanisms for circulating α-Klotho levels
por: Gergei, Ingrid, et al.
Publicado: (2021)

The Roles of Sclerostin in Immune System and the Applications of Aptamers in Immune-Related Research
por: Sun, Meiheng, et al.
Publicado: (2021)

Gender-Related Impact of Sclerostin Antibody on Bone in the Osteogenesis Imperfecta Mouse
por: Cardinal, Mickaël, et al.
Publicado: (2021)

Circulating miRNA-29b and Sclerostin Levels Correlate with Coronary Artery Calcification and Cardiovascular Events in Maintenance Hemodialysis Patients
por: He, Jiqing, et al.
Publicado: (2021)

The Effect of Renal Dysfunction on Circulating Sclerostin Level in Patients with Type 2 Diabetes
por: Kim, Se Hwa, et al.
Publicado: (2014)

Circulating sclerostin is not suppressed following a single bout of exercise in young men
por: Guerriere, Katelyn I., et al.
Publicado: (2018)

Circulating levels of sclerostin but not DKK1 associate with laboratory parameters of CKD-MBD
por: Behets, Geert J., et al.
Publicado: (2017)

The association of circulating sclerostin level with markers of bone metabolism in patients with thyroid dysfunction
por: Mihaljević, Olgica, et al.
Publicado: (2020)

Apolipoprotein CIII predicts cardiovascular events in patients with coronary artery disease: a prospective observational study
por: Katzmann, Julius L., et al.
Publicado: (2020)

Serum sclerostin levels are positively related to bone mineral density in peritoneal dialysis patients: a cross-sectional study
por: Kuo, Te-Hui, et al.
Publicado: (2019)

Sclerostin and Vascular Pathophysiology
por: Catalano, Antonino, et al.
Publicado: (2020)

Subclinical inflammation, telomere shortening, homocysteine, vitamin B6, and mortality: the Ludwigshafen Risk and Cardiovascular Health Study
por: Pusceddu, Irene, et al.
Publicado: (2019)

Sclerostin and TNF-related weak inducer of apoptosis: can they be important in the patients with glomerulonephritis?
por: Ozer, Hakan, et al.
Publicado: (2023)

Sclerostin Inhibition in the Management of Osteoporosis
por: Appelman-Dijkstra, Natasha M., et al.
Publicado: (2016)

The Role of Sclerostin in Bone Diseases
por: Vasiliadis, Elias S., et al.
Publicado: (2022)

Drug discovery of sclerostin inhibitors
por: Yu, Sifan, et al.
Publicado: (2022)

The Effect of Sclerostin and Monoclonal Sclerostin Antibody Romosozumab on Osteogenesis and Osteoclastogenesis Mediated by Periodontal Ligament Fibroblasts
por: Pigeaud, Karina E., et al.
Publicado: (2023)

Bone Sclerostin and Dickkopf-related protein-1 are positively correlated with bone mineral density, bone microarchitecture, and bone strength in postmenopausal osteoporosis
por: Peng, Jia, et al.
Publicado: (2021)

Parathyroid Hormone Regulates Circulating Levels of Sclerostin and FGF23 in a Primary Hyperparathyroidism Model
por: Nagata, Yuki, et al.
Publicado: (2022)

Circulating SIRT1 and Sclerostin Correlates with Bone Status in Young Women with Different Degrees of Adiposity
por: Tozzi, Rossella, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_c4afqjp98q1d55mc251n41jtmg